cytochalasin-d and 4-bromophenacyl-bromide

cytochalasin-d has been researched along with 4-bromophenacyl-bromide* in 3 studies

Other Studies

3 other study(ies) available for cytochalasin-d and 4-bromophenacyl-bromide

ArticleYear
4-Bromophenacyl bromide specifically inhibits rhoptry secretion during Toxoplasma invasion.
    PloS one, 2009, Dec-02, Volume: 4, Issue:12

    Toxoplasma gondii is a eukaryotic parasite of the phylum Apicomplexa that is able to infect a wide variety of host cells. During its active invasion process it secretes proteins from discrete secretory organelles: the micronemes, rhoptries and dense granules. Although a number of rhoptry proteins have been shown to be involved in important interactions with the host cell, very little is known about the mechanism of secretion of any Toxoplasma protein into the host cell. We used a chemical inhibitor of phospholipase A2s, 4-bromophenacyl bromide (4-BPB), to look at the role of such lipases in the secretion of Toxoplasma proteins. We found that 4-BPB was a potent inhibitor of rhoptry secretion in Toxoplasma invasion. This drug specifically blocked rhoptry secretion but not microneme secretion, thus effectively showing that the two processes can be de-coupled. It affected parasite motility and invasion, but not attachment or egress. Using propargyl- or azido-derivatives of the drug (so-called click chemistry derivatives) and a series of 4-BPB-resistant mutants, we found that the drug has a very large number of target proteins in the parasite that are involved in at least two key steps: invasion and intracellular growth. This potent compound, the modified "click-chemistry" forms of it, and the resistant mutants should serve as useful tools to further study the processes of Toxoplasma early invasion, in general, and rhoptry secretion, in particular.

    Topics: Acetophenones; Animals; Cell Adhesion; Cell Nucleus; Cytochalasin D; Humans; Membrane Proteins; Movement; Mutation; Parasites; Protozoan Proteins; Toxoplasma; Vacuoles

2009
Inhibition of neutrophil spreading during adhesion to fibronectin reveals formation of long tubulovesicular cell extensions (cytonemes).
    Experimental cell research, 2001, Jun-10, Volume: 266, Issue:2

    Human neutrophils developed long thin tubulovesicular extensions (cytonemes) upon adhesion to fibronectin-coated substrata, when spreading was blocked. We observed extension formation when neutrophils were plated to fibronectin-coated substrata in Na(+)-free extracellular medium or in the presence of drugs capable of inhibiting spreading: 4-bromophenacyl bromide, N-ethylmaleimide, 7-chloro-4-nitrobenz-2-oxa-1,3-diazole, and cytochalasin D. Addition of Na(+) ions or washing of inhibitors restored neutrophil spreading. Phase-contrast and scanning electron microscopy revealed two types of extensions: (1) highly dynamic, flexible tubulovesicular extensions with unattached tips 0.2-0.4 microm in diameter, which can achieve 70-80 microm in length during 20 min, and (2) thinner straight extensions with flattened tips, which were formed in the presence of phorbol 12-myristate 13-acetate and connected cells to substratum or to the neighboring cells several cell diameters away. The latter may have derived from the former through tension after attachment of the tips. Spreading and extension formation may represent two states of the cell adhesive and communicative mechanism.

    Topics: 4-Chloro-7-nitrobenzofurazan; Acetophenones; Antibodies, Monoclonal; Cell Adhesion; Cells, Cultured; Cytochalasin D; Ethylmaleimide; Fibronectins; Humans; Integrins; L-Selectin; Microscopy, Electron, Scanning; Neutrophils; Pseudopodia; Tetradecanoylphorbol Acetate

2001
Fc gamma 2b receptor-mediated prostaglandin synthesis by a murine macrophage cell line (P388D1).
    Journal of immunology (Baltimore, Md. : 1950), 1982, Volume: 128, Issue:6

    The nature of signals transmitted by two types of Fc gamma receptors (one specific for IgG2b and the other for IgG2a) present on the surface of a murine macrophage cell line (P388D1) was investigated. Specific binding of IgG2b (presented as EA2b) to cell surface Fc gamma 2br triggered the release of 3H-arachidonic acid and 3H-prostaglandins (PG) from P388D1 cells that were prelabeled with 3H-arachidonate. The release of 3H-arachidonic acid, which increased in a dose-dependent manner, was enhanced by exogenous Ca++ (1.25 mM) and was completely blocked by ethylenediaminetetraacetate (EDTA) (4 mM) or a phospholipase A2 inhibitor, p-bromophenacylbromide (7 microgram/ml). A cyclooxygenase inhibitor, indomethacin (9 microgram/ml), reduced the 3H-arachidonic acid release and completely blocked the conversion of arachidonate into PG. Cytochalasin D (1 microgram/ml), which inhibited the phagocytosis of immune complexes by 90% of P388D1 cells, did not affect the Fc gamma 2bR-triggered release of arachidonic acid. Specific binding of IgG2a (presented as EA2a) to cell surface Fc gamma 2aR did not trigger the release of either 3H-arachidonic acid or 3H-PG from P388D1 cells. Our data demonstrate a signal for the activation of the arachidonic acid metabolic cascade is transmitted by Fc gamma 2bR, but not by Fc gamma 2aR, on the surface of P388D1 cells, probably through the initial activation of the phospholipase A2 activity associated with Fc gamma 2bR.

    Topics: Acetophenones; Animals; Arachidonic Acid; Arachidonic Acids; Calcium; Cell Line; Chromatography, Thin Layer; Cytochalasin D; Cytochalasins; Edetic Acid; Indomethacin; Macrophages; Mice; Phagocytosis; Prostaglandins; Receptors, Fc; Receptors, IgG; Receptors, Immunologic; Rosette Formation

1982